Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 4 boards, counting each seat separately. Longest: Aprea Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Adicet Bio Inc. June 17, 202698.0%
-
Aprea Therapeutics Inc. June 20, 202498.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 2026 | Aprea Therapeutics Inc. | Grant or award | +3,135 | — | — |
| Jun 5, 2025 | Aprea Therapeutics Inc. | Grant or award | +1,045 | — | — |
| Jun 20, 2024 | Aprea Therapeutics Inc. | Grant or award | +1,045 | — | — |
| Aug 23, 2023 | Aprea Therapeutics Inc. | Grant or award | +500 | — | — |
Questions about Michael Grissinger
What boards is Michael Grissinger on?
Michael Grissinger sits on the boards of Adicet Bio Inc., Akari Therapeutics plc, Aprea Therapeutics Inc. and Lipocine Inc.
How long has Michael Grissinger served on boards?
Our records show at least 8 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.